PD17-11 PHASE II CLINICAL TRIAL: SHORT-TERM ONCOLOGIC OUTCOMES OF NANOPARTICLE-DIRECTED FOCAL PHOTOTHERMAL LASER ABLATION

INTRODUCTION AND OBJECTIVE:Whole gland treatment of low and intermediate risk prostate cancer (PCa) results in substantial morbidity with variable survival benefit. Focal therapy of PCa may be an a...